Relationship between Persistent Gastrointestinal Symptoms and Duodenal Histological Findings after Adequate Gluten-Free Diet: A Gray Area of Celiac Disease Management in Adult Patients

• Published in: Nutrients 2021-02, Vol.13 (2), p.600
• Main Authors: Galli, Gloria, Carabotti, Marilia, Pilozzi, Emanuela, Lahner, Edith, Annibale, Bruno, Conti, Laura
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Adults; Aged; Celiac disease; Celiac Disease - complications; Celiac Disease - diet therapy; Celiac Disease - pathology; Constipation - diet therapy; Constipation - etiology; Constipation - pathology; Diet; Diet, Gluten-Free; Disease Management; duodenal histology; Duodenum - pathology; Female; gastrointestinal symptoms; Gluten; gluten-free diet; Humans; Intestinal Absorption; Longitudinal Studies; malabsorption signs; Male; Medical research; Medicine, Experimental; Middle Aged; Patient Compliance; slow responders; Symptom Assessment; Time Factors; Treatment Outcome; Young Adult
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu13020600

A gluten-free diet (GFD) leads to a rapid improvement in gastrointestinal (GI) symptoms, biochemical alterations and duodenal histological damage in the majority of celiac disease (CD) patients. This study aimed to assess the frequency and factors associated with the persistence of GI symptoms/malabsorption signs and their relationship with duodenal histological findings among CD patients on an adequate GFD (mean duration 16 months, range 12-28 months). This longitudinal cohort study included 102 adult CD patients (median age 38.5 years, range 18-76 years, F = 71.6%) diagnosed between 2012 and 2018. A total of 36.3% of the included patients had persistent GI symptoms and/or malabsorption signs (Group 1), while the remaining patients had complete GI well-being without malabsorption signs (Group 2) at the time of histological re-evaluation. The persistence of GI symptoms/signs was associated with a long duration of symptoms/signs before CD diagnosis (≥5 years) (OR 5.3; 95% CI 1.3-21.8) and the presence of constipation at the time of CD diagnosis (OR 7.5; 95% CI 1.3-42) while for other variables, including age at CD diagnosis, sex, duration of GFD, comorbidities, CD serology positivity and severity of duodenal damage at histological re-evaluation, no association was found. According to our results, the persistence of symptoms/signs is not associated with histological findings, and their relationship could be a gray area in CD management.